Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder.
about
The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activityMechanisms of dopamine transporter regulation in normal and disease statesSpontaneous inward opening of the dopamine transporter is triggered by PIP2-regulated dynamics of the N-terminusDopamine receptors - IUPHAR Review 13The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants.Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood.Missense dopamine transporter mutations associate with adult parkinsonism and ADHD.The effect of modafinil on the rat dopamine transporter and dopamine receptors D1-D3 paralleling cognitive enhancement in the radial arm mazeDuration-dependence of the effect of treadmill exercise on hyperactivity in attention deficit hyperactivity disorder ratsDe novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorderPIP2 regulates psychostimulant behaviors through its interaction with a membrane protein.Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.Effect of atomoxetine on hyperactivity in an animal model of attention-deficit/hyperactivity disorder (ADHD).Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism.Dopamine transporter endocytic trafficking in striatal dopaminergic neurons: differential dependence on dynamin and the actin cytoskeleton.Regulation of monoamine transporters: Role of transporter phosphorylation.Effect of treadmill exercise on social interaction and tyrosine hydroxylase expression in the attention-deficit/ hyperactivity disorder rats.Computational modeling of the N-terminus of the human dopamine transporter and its interaction with PIP2 -containing membranes.Both stereoselective (R)- and (S)-1-Methyl-1,2,3,4-tetrahydroisoquinoline enantiomers protect striatal terminals against rotenone-induced suppression of dopamine release.Effect of exercise on hyperactivity, impulsivity and dopamine D2 receptor expression in the substantia nigra and striatum of spontaneous hypertensive rats.SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking.Rare autism-associated variants implicate syntaxin 1 (STX1 R26Q) phosphorylation and the dopamine transporter (hDAT R51W) in dopamine neurotransmission and behaviors.Identification of a novel selective serotonin reuptake inhibitor by coupling monoamine transporter-based virtual screening and rational molecular hybridizationAttention-deficit/hyperactivity disorder in relation to addictive behaviors: a moderated-mediation analysis of personality-risk factors and sex.Functional mechanisms of neurotransmitter transporters regulated by lipid-protein interactions of their terminal loops.Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation.Reciprocal Phosphorylation and Palmitoylation Control Dopamine Transporter Kinetics.Dopamine Transporter Activity Is Modulated by α-Synuclein.ADHD-associated dopamine transporter, latrophilin and neurofibromin share a dopamine-related locomotor signature in DrosophilaAcute administration of dopaminergic drugs has differential effects on locomotion in larval zebrafishProtein kinase Cβ is a modulator of the dopamine D2 autoreceptor-activated trafficking of the dopamine transporter.Membrane-permeable C-terminal dopamine transporter peptides attenuate amphetamine-evoked dopamine release.Transgenic mouse models for ADHD.Vesicular and plasma membrane transporters for neurotransmitters.In vitro study methodologies to investigate genetic aspects and effects of drugs used in attention-deficit hyperactivity disorder.A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD).Brain tissue responses to neural implants impact signal sensitivity and intervention strategies.Phospho-specific antibodies targeting the amino terminus of the human dopamine transporter.HIV, Tat and dopamine transmission.
P2860
Q22242368-6DE52565-D297-408E-BC20-95FC40A74322Q24598750-8A7CC9C5-77F4-4F72-BBA3-A1866C78F605Q27300323-47DD9482-7A10-4B89-B86E-1C5B64F7F901Q28256783-8FC0C0CB-A0A3-486D-A574-45BAA4D00BA9Q30412810-21FAF0A1-9F55-488B-A621-D95FAB394EA8Q30574381-2B86DF88-5552-4D19-82B3-FB056474C82CQ30581669-BAEE3817-7FB9-4587-96EF-76F4F6461133Q30661702-8470DEB0-505D-41B4-B005-E51518FA7E59Q33629859-8C8685BD-335B-4DFC-AC91-9D40D060A550Q33715513-E6001880-A7F0-4D37-8CA9-2A3A23BA237FQ33773594-357704F0-E5BC-435F-959F-156AA70CBA15Q34161514-31A04A33-CE32-4792-AFF9-08A836536095Q34257043-62334A4E-5A59-4CC1-9CF2-29575DEF2A1EQ34278294-312BDC71-5ED6-444E-94C1-D9AA57AD1994Q34302349-0AAB5B0A-2871-4166-9966-F9EC2F445362Q34383082-490C794D-827A-48EA-9E59-0AAAA49BF210Q34540543-B41D2901-62D6-4A94-B24C-12CCD6B15F23Q34544656-EF07222A-6812-4C30-81A8-9DA5BFD3613CQ34668331-2671818E-FA0F-4F82-9B89-5425F8F5450DQ35031643-FED70B43-E6D0-468D-9135-0ED51879BD9DQ35064823-12B697E5-69D6-43C7-9605-240723FFD423Q35150201-323CB646-0F3B-4772-AB47-A759568EB6F9Q35160047-90A17A0C-4B94-45CE-BC66-CA464BFFF8EFQ35234897-A2F47093-BDFF-4B43-BF9E-94790EF757BAQ35486676-AEABCFE7-487A-4A7D-A65A-D63788663733Q35850518-683C157A-5274-4AFC-ACA5-17105A02104EQ35927547-751F7CDC-41A7-4B1E-8287-6E59FF30E060Q36323546-E0CBC5B8-6E82-48E5-B881-9DC828DC21DDQ36444116-7A173AE0-6F6F-4B9B-BB5D-48B69E87D671Q36719177-A486AF7E-17ED-4C72-B558-80458058F2FAQ36808288-2446263B-B798-4D09-AF0B-3D74C6C31553Q36864278-8FC7F2EF-C938-445B-86AC-2AAE6F37DBBDQ37189583-781FFBD7-3F32-4065-9134-E41FE5D176F2Q37203801-5302AB6B-0739-459D-A581-5E5C61F48880Q37971367-38768C8B-52AA-43C9-85FF-5634891329B5Q38029532-A1BBDE2F-6924-4116-8CCE-76003CCF751FQ38164670-1397AA67-4B70-4E2D-833D-CC5C90F60B11Q38302762-5608D02A-123F-4982-AA06-7878ABB0C411Q38750344-DB4E6FE1-5FA9-463C-8B30-918EAA4841E2Q38812005-B59D8375-2D80-4FF8-8005-00020A33DFA9
P2860
Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Dysregulation of dopamine tran ...... eficit hyperactivity disorder.
@ast
Dysregulation of dopamine tran ...... eficit hyperactivity disorder.
@en
type
label
Dysregulation of dopamine tran ...... eficit hyperactivity disorder.
@ast
Dysregulation of dopamine tran ...... eficit hyperactivity disorder.
@en
prefLabel
Dysregulation of dopamine tran ...... eficit hyperactivity disorder.
@ast
Dysregulation of dopamine tran ...... eficit hyperactivity disorder.
@en
P2093
P2860
P50
P1476
Dysregulation of dopamine tran ...... eficit hyperactivity disorder.
@en
P2093
Aurelio Galli
Christine Saunders
Erica Bowton
Kevin Erreger
Marc G Caron
Namita Sen
Randy D Blakely
Tammy Jessen
P2860
P304
P356
10.1523/JNEUROSCI.5094-09.2010
P407
P577
2010-04-01T00:00:00Z